| FSMAX | TMDPX | FSMAX / TMDPX | |
| Total Expense Ratio | 0.04 | 1.06 | 3% |
| Annual Report Gross Expense Ratio | 0.04 | 1.06 | 3% |
| Fund Existence | 15 years | 21 years | - |
| Gain YTD | 13.668 | 4.191 | 326% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 42.7B | 1.64B | 2,607% |
| Annual Yield % from dividends | 0.50 | 0.00 | - |
| Returns for 1 year | 30.51 | -3.93 | -777% |
| Returns for 3 years | 71.53 | 12.60 | 568% |
| Returns for 5 years | 37.00 | -21.66 | -171% |
| Returns for 10 years | 141.36 | -10.27 | -1,377% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AFMBX | 41.01 | N/A | N/A |
| American Fds American Balanced F-3 | |||
| FEDGX | 22.03 | N/A | N/A |
| Fidelity Advisor Emerg Mkts Discv C | |||
| JEPSX | 13.77 | N/A | N/A |
| JPMorgan Equity Premium Income R5 | |||
| ANVHX | 10.99 | N/A | N/A |
| American Century Non-US Intrs Val I | |||
| CEFAX | 19.55 | N/A | N/A |
| Calvert Emerging Markets Advancement A | |||